Universal flu vaccine: Difference between revisions
CSV import |
CSV import |
||
| Line 34: | Line 34: | ||
[[Category:Influenza]] | [[Category:Influenza]] | ||
[[Category:Public health]] | [[Category:Public health]] | ||
<gallery> | |||
File:3D_Influenza_virus.png|3D model of the Influenza virus | |||
File:Prototype_for_a_Universal_Flu_Vaccine_(48706389381).png|Prototype for a Universal Flu Vaccine | |||
</gallery> | |||
Latest revision as of 01:19, 18 February 2025
A vaccine intended to provide protection against all influenza strains


A universal flu vaccine is a vaccine that would provide broad protection against all influenza virus strains. Unlike the seasonal flu vaccines, which are updated annually to match the most prevalent strains, a universal flu vaccine aims to offer long-lasting immunity against multiple subtypes of the influenza virus.
Background[edit]
Influenza is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness and at times can lead to death. The World Health Organization (WHO) estimates that annual influenza epidemics result in about 3 to 5 million cases of severe illness and about 290,000 to 650,000 respiratory deaths worldwide.
The current seasonal flu vaccines are designed to protect against the three or four influenza viruses that research indicates will be most common during the upcoming season. However, these vaccines need to be reformulated each year due to the high mutation rate of the influenza virus, which can lead to antigenic drift and antigenic shift.
Research and Development[edit]
Research into a universal flu vaccine focuses on targeting parts of the virus that are less prone to mutation. One approach is to target the hemagglutinin (HA) stalk, a part of the virus that is more conserved across different strains. Another strategy involves targeting the neuraminidase (NA) protein or the M2 protein, which are also more conserved.
Several candidates for a universal flu vaccine are in various stages of development. These include vaccines based on virus-like particles, recombinant DNA technology, and mRNA platforms. Some of these candidates have shown promise in preclinical studies and early-stage clinical trials.
Challenges[edit]
Developing a universal flu vaccine presents several challenges. The influenza virus is highly variable, and its ability to mutate rapidly makes it difficult to create a vaccine that can provide broad and long-lasting protection. Additionally, the immune response to influenza is complex, and understanding how to elicit a protective response against all strains is a significant scientific challenge.
Potential Impact[edit]
A successful universal flu vaccine could transform public health by reducing the burden of influenza worldwide. It could eliminate the need for annual vaccinations and provide protection against pandemic strains, potentially saving millions of lives and reducing healthcare costs.
Related pages[edit]
References[edit]
<references group="" responsive="1"></references>
-
3D model of the Influenza virus
-
Prototype for a Universal Flu Vaccine